Platform technology to generate broadly cross-reactive antibodies to α-helical epitopes in hemagglutinin proteins from influenza a viruses.
| Image |  |
|---|---|
| Description | scientific article published on 21 January 2016 |
| Author/s | |
| Publication date | March 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |